An international research team has revealed the atomic‐level structure of the human peptidase enzyme meprin beta. The enzyme is related to inflammation, cancer and Alzheimer’s disease and is involved in cellular proliferation and differentiation. The knowledge of the enzyme structure will allow for the development of a new medication type different from those known up to now.